Literature DB >> 24908281

Associations between serum hepcidin level, FGF-21 level and oxidative stress with arterial stiffness in CAPD patients.

Sena Memnune Ulu1, Seref Yuksel, Atila Altuntaş, Emre Kacar, Ahmet Ahsen, Abdullah Altug, Sefa Celik, M Tugrul Sezer.   

Abstract

BACKGROUND: Patients on continuous ambulatory peritoneal dialysis (CAPD) and hemodialysis have accelerated atherosclerosis associated with an increase in cardiovascular morbidity and mortality. Atherosclerosis is associated with increased arterial stiffness (AS), endothelial dysfunction and elevated oxidative stress (OS) and inflammation. We aimed to investigate the relationship between oxidative stress status, arterial stiffness, hepcidin and fibroblast growth factor-21 (FGF-21) levels in CAPD patients.
METHODS: As a prospective observational study, we analyzed 56 CAPD patients, aged between 30 and 63 years. Serum hepcidin, FGF-21 levels, OS status and AS were determined. Arterial stiffness was measured by flow-mediated dilatation (FMD). Oxidative stress status was determined by total antioxidant status, total oxidant status (TOS) and oxidative stress index (OSI).
RESULTS: FMD was negatively correlated with TOS, OSI, hepcidin and FGF-21 (r: -0.313, p: 0.020; r: -0.0331, p: 0.014; r: -0.498, p < 0.001; r: -0.403, p: 0.002, respectively). OSI was positively correlated with hepcidin, parathormone and negatively correlated with FMD (r: 0.278, p: 0.040; r: 0.462, p < 0.001; r: -0.0331, p: 0.014, respectively).
CONCLUSION: There are many factors affecting arterial stiffness in CAPD patients. In our study, higher levels of OS status, hepcidin and FGF-21 were independent determinants of arterial stiffness in PD patients. Therefore, definition and improvement of these new parameters will be helpful to reduce the cardiovascular disease risk and mortality in CAPD patients.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24908281     DOI: 10.1007/s11255-014-0753-7

Source DB:  PubMed          Journal:  Int Urol Nephrol        ISSN: 0301-1623            Impact factor:   2.370


  42 in total

1.  A novel automated direct measurement method for total antioxidant capacity using a new generation, more stable ABTS radical cation.

Authors:  Ozcan Erel
Journal:  Clin Biochem       Date:  2004-04       Impact factor: 3.281

2.  Cardiovascular disease in haemodialysis and peritoneal dialysis: arguments pro peritoneal dialysis.

Authors:  Wim Van Biesen; Francis Verbeke; Francio Verbeke; Raymond Vanholder
Journal:  Nephrol Dial Transplant       Date:  2006-10-18       Impact factor: 5.992

3.  Cu/Zn ratios are associated with nutritional status, oxidative stress, inflammation, and immune abnormalities in patients on peritoneal dialysis.

Authors:  Chih-Hung Guo; Pei-Chung Chen; Maw-Sheng Yeh; Der-Yun Hsiung; Chia-Liang Wang
Journal:  Clin Biochem       Date:  2011-01-09       Impact factor: 3.281

4.  Determinants of hepcidin in patients on maintenance hemodialysis: role of inflammation.

Authors:  Takahiro Kuragano; Yasushi Shimonaka; Aritoshi Kida; Minoru Furuta; Masayoshi Nanami; Yoshinaga Otaki; Yukiko Hasuike; Hiroshi Nonoguchi; Takeshi Nakanishi
Journal:  Am J Nephrol       Date:  2010-05-14       Impact factor: 3.754

5.  Serum hepcidin in haemodialysis patients: associations with iron status and microinflammation.

Authors:  Y Xu; X Q Ding; J Z Zou; Z H Liu; S H Jiang; Y M Chen
Journal:  J Int Med Res       Date:  2011       Impact factor: 1.671

6.  A new automated colorimetric method for measuring total oxidant status.

Authors:  Ozcan Erel
Journal:  Clin Biochem       Date:  2005-10-07       Impact factor: 3.281

7.  Vascular calcification and cardiovascular function in chronic kidney disease.

Authors:  Mhairi Sigrist; Peter Bungay; Maarter W Taal; Christopher W McIntyre
Journal:  Nephrol Dial Transplant       Date:  2005-11-01       Impact factor: 5.992

8.  The influence of dialytic modality on arterial stiffness, pulse wave reflections, and vasomotor function.

Authors:  Adrian Covic; David J A Goldsmith; Laura Florea; Paul Gusbeth-Tatomir; Maria Covic
Journal:  Perit Dial Int       Date:  2004 Jul-Aug       Impact factor: 1.756

9.  Impact of aortic stiffness on survival in end-stage renal disease.

Authors:  J Blacher; A P Guerin; B Pannier; S J Marchais; M E Safar; G M London
Journal:  Circulation       Date:  1999-05-11       Impact factor: 29.690

10.  The factors that affect plasma homocysteine levels, pulse wave velocity and their relationship with cardiovascular disease indicators in peritoneal dialysis patients.

Authors:  Sibel Ertek; Ayse Nur Torun; Kenan Ates
Journal:  Int Urol Nephrol       Date:  2009-08-04       Impact factor: 2.370

View more
  12 in total

Review 1.  Fibroblast growth factor 21 in chronic kidney disease.

Authors:  Paulo Giovanni de Albuquerque Suassuna; Rogério Baumgratz de Paula; Hélady Sanders-Pinheiro; Orson W Moe; Ming-Chang Hu
Journal:  J Nephrol       Date:  2018-11-14       Impact factor: 3.902

Review 2.  Arterial stiffness and increased cardiovascular risk in chronic kidney disease.

Authors:  Yuxia Ma; Lin Zhou; Jinghui Dong; Xiaoshen Zhang; Shi Yan
Journal:  Int Urol Nephrol       Date:  2015-05-20       Impact factor: 2.370

Review 3.  In-depth review: is hepcidin a marker for the heart and the kidney?

Authors:  Rengin Elsurer Afsar; Mehmet Kanbay; Avsin Ibis; Baris Afsar
Journal:  Mol Cell Biochem       Date:  2021-05-04       Impact factor: 3.396

4.  The metabolic hormone FGF21 is associated with endothelial dysfunction in hemodialysis patients.

Authors:  Crina Claudia Rusu; Simona Racasan; Ina Maria Kacso; Diana Moldovan; Alina Potra; Dacian Tirinescu; Cristian Budurea; Remus Orasan; Ioan Mihai Patiu; Cosmina Ioana Bondor; Dan Vladutiu; Mirela Gherman Caprioara
Journal:  Int Urol Nephrol       Date:  2016-12-10       Impact factor: 2.370

5.  Serum fibroblast growth factor 21 levels is associated with lower extremity atherosclerotic disease in Chinese female diabetic patients.

Authors:  Xiaoyan Zhang; Yanyun Hu; Hui Zeng; Lianxi Li; Jungong Zhao; Jun Zhao; Fang Liu; Yuqian Bao; Weiping Jia
Journal:  Cardiovasc Diabetol       Date:  2015-03-11       Impact factor: 9.951

6.  Fibroblast Growth Factor 21 (FGF-21) in Peritoneal Dialysis Patients: Natural History and Metabolic Implications.

Authors:  Elena González; Juan J Díez; M Auxiliadora Bajo; Gloria del Peso; Cristina Grande; Olaia Rodríguez; Mariana Díaz-Almirón; Pedro Iglesias; Rafael Selgas
Journal:  PLoS One       Date:  2016-03-17       Impact factor: 3.240

7.  Serum Hepcidin-25 and Risk of Mortality in Patients on Peritoneal Dialysis.

Authors:  Zhong Zhong; Dan Luo; Ning Luo; Bin Li; Dongying Fu; Li Fan; Zhijian Li; Wei Chen; Haiping Mao
Journal:  Front Med (Lausanne)       Date:  2021-06-17

8.  Relation between high serum hepcidin-25 level and subclinical atherosclerosis and cardiovascular mortality in hemodialysis patients.

Authors:  Özlem Yayar; Barış Eser; Harun Kılıç
Journal:  Anatol J Cardiol       Date:  2018-01-17       Impact factor: 1.596

Review 9.  Cholesterol Efflux: Does It Contribute to Aortic Stiffening?

Authors:  Shutan Liao; Craig S McLachlan
Journal:  J Cardiovasc Dev Dis       Date:  2018-05-01

10.  Pulse Wave Velocity Is Associated with Increased Plasma oxLDL in Ageing but Not with FGF21 and Habitual Exercise.

Authors:  Shuen Yee Lee; Stephen F Burns; Kenneth K C Ng; David J Stensel; Liang Zhong; Frankie H Y Tan; Kar Ling Chia; Kai Deng Fam; Margaret M C Yap; Kwee Poo Yeo; Eric P H Yap; Chin Leong Lim
Journal:  Antioxidants (Basel)       Date:  2020-03-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.